Tech Company Financing Transactions
Topica Pharmaceuticals Funding Round
Topica Pharmaceuticals closed a $4.5 million Series B funding round on 6/11/2013. Backers included private investors.
Transaction Overview
Company Name
Announced On
6/11/2013
Transaction Type
Venture Equity
Amount
$4,519,071
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing-amended.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4300 El Camino Real 101
Los Altos, CA 94022
USA
Los Altos, CA 94022
USA
Phone
Website
Email Address
Overview
Topica Pharmaceuticals, Inc. is a privately held, clinical-stage specialty pharmaceutical company focused exclusively on developing the first highly effective, safe and convenient topical treatment for onychomycosis, or fungal infections of the toenail and nail bed.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Greg Vontz
Chief Financial Officer
Joseph Golemme
VP - General Counsel
Stephen Rosenfield
VP - Product Management
Katy Morton
VP - R & D
Norifumi Nakamura
Browse more venture capital transactions:
Prev: 6/11/2013: ZetrOz venture capital transaction
Next: 6/11/2013: TipTap venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs